Results 221 to 230 of about 3,928,328 (244)

Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation. [PDF]

Pharmaceut Med
Bartlett JA, Culver N, Santangelo M, Prpich A, Long E, Sagawa K, Shanker R, Xu H, Wilner K.   +8 more
europepmc   +1 more source

Analysis of the Stability of Compounded Vancomycin Hydrochloride Oral Solution: A Comparison Between Formulations Prepared Using a Commercial Product and Using the Pure Active Ingredient. [PDF]

Cureus
Arroyo-Solorzano JD, Martínez-Carpio S, Blanco-Barrantes J, Pacheco-Molina J, Loría-Gutiérrez A, Arguedas-Chacón S, Zavaleta-Monestel E.   +6 more
europepmc   +1 more source

Review of Structural Modification and Development of Novel Tramadol Derivatives. [PDF]

Molecules
Wang N, Zhou X, Wang J, Sun L, Liu B, Yin L.   +5 more
europepmc   +1 more source

Explainable AI in Pharmaceutics: Grad-CAM Analysis of Surface Dissolution Imaging Using Convolutional Neural Networks. [PDF]

Pharmaceutics
Al-Baghdadi A, Pacławski A, Szlęk J, Mendyk A.   +3 more
europepmc   +1 more source

Hydrochlorides, hydrates, hydronitrate, and an unanticipated hydrolysis product of famotidine. [PDF]

Acta Crystallogr C Struct Chem
Weaver MC, Oliver AG, Barstis TLO.
europepmc   +1 more source

Identifying new solid forms of a labile pharmaceutical compound by additive assisted mechanochemistry.

RSC Mechanochem
Hadjipour A, Crown NY, Gayatri G, Kavanagh ON.   +3 more
europepmc   +1 more source

Influence of pH, Temperature and Impurities on the Solubility of an Active Pharmaceutical Ingredient (API) [PDF]

International Journal of Chemical Reactor Engineering, 2010
Solubility, which defines the liquid /solid equilibrium, is a key parameter to control a crystallization process. This work is focused on the effects of pH, temperature and impurities on the aqueous solubility of an Active Pharmaceutical Ingredient (API).
Beatrice Biscans, Sébastien Teychene
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Common Deficiencies Found in the Active Pharmaceutical Ingredient (API) Section of Non-sterile Generic Products Submitted for Registration by SAHPRA

Therapeutic Innovation and Regulatory Science, 2021
Jacques Joubert
exaly  

Process analytical technology-based (PAT) model simulations of a combined cooling, seeded and antisolvent crystallization of an active pharmaceutical ingredient (API)

Powder Technology, 2020
Blaz Likozar, Marko Trampuz
exaly